Analyzing fatal cases of Chinese patients with primary antineutrophil cytoplasmic antibodies-associated renal vasculitis: A 10-year retrospective study

Kidney and Blood Pressure Research

Volumn 31, Issue 5, 2008, Pages 343-349

  Chen, Yong Xi ^a   Yu, Hai Jin ^a   Zhang, Wen ^a   Ren, Hong ^a   Chen, Xiao Nong ^a   Shen, Ping Yan ^a   Xu, Yao Wen ^a   Li, Xiao ^a   Pan, Xiao Xia ^a   Ni, Li Yan ^a   Wang, Wei Ming ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antineutrophil cytoplasmic antibodies; Vasculitis

Indexed keywords

CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ACUTE HEART INFARCTION; ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CAUSE OF DEATH; CHINESE; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; INFECTION PREVENTION; KIDNEY FAILURE; LOW DRUG DOSE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC POLYANGIITIS; MORTALITY; PERITONEAL DIALYSIS; PLASMAPHERESIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; STOMACH CARCINOMA; WEGENER GRANULOMATOSIS;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ASIAN CONTINENTAL ANCESTRY GROUP; CAUSE OF DEATH; FEMALE; HUMANS; INFECTION; KIDNEY DISEASES; MALE; MIDDLE AGED; RENAL INSUFFICIENCY; RETROSPECTIVE STUDIES; VASCULITIS;

EID: 54149101329     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000165117     Document Type: Article

References (24)

1. Jennette JC, Falk RJ, Andrassy K, et al: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
2. Bosch X, Guilabert A, Font J: Antineutrophil cytoplasmic antibodies. Lancet 2006;368:404-418.
3. Fauci AS, Haynes BF, Katz P, Wolff SM: Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98:76-85.
4. Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, Rottem M, Fauci AS: Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-498.
5. Booth AD, Almond MK, Burns A, Ellis P, Gaskin G, Neild GH, Plaisance M, Pusey CD, Jayne DR: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003;41:776-784.
6. Harper L, Savage CO: Anca-associated renal vasculitis at the end of the twentieth century - a disease of older patients. Rheumatology (Oxford) 2005;44:495-501.
7. Leavitt RY, Fauci AS, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33:1101-1107.
8. Masi AT, Hunder GG, Lie JT, et al: The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-1100.
9. Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
10. Flossmann O, Bacon P, de Groot K, Jayne D, Rasmussen N, Seo P, Westman K, Luqmani R: Development of comprehensive disease assessment in systemic vasculitis. Ann Rheum Dis 2007;66:283-292.
11. Chen YX, Yu HJ, Ni LY, Zhang W, Xu YW, Ren H, Chen XN, Wang XL, Li X, Pan XX, Wang WM, Chen N: Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol 2007;34:2451-2456.
12. Morgan MD, Harper L, Williams J, Savage C: Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 2006;17:1224-1234.
13. Kallenberg CG: Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Curr Opin Rheumatol 2007;19:17-24.
14. Rihova Z, Jancova E, Merta M, Rysava R, Reiterova J, Zabka J, Tesar V: Long-term outcome of patients with antineutrophil cytoplasmic autoantibody-associated vasculitis with renal involvement. Kidney Blood Press Res 2005;28:144-152.
15. Aasarod K, Iversen BM, Hammerstrom J, Bostad L, Vatten L, Jorstad S: Wegener's granulomatosis: clinical course in 108 patients with renal involvement. Nephrol Dial Transplant 2000;15:2069.
16. Slot MC, Tervaert JW, Franssen CF, Stegeman CA: Renal survival and prognostic factors in patients with pr3-ANCA associated vasculitis with renal involvement. Kidney Int 2003;63:670-677.
17. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD: Anca-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004;19:1403-1411.
18. de Lind van Wijngaarden RA, Hauer HA, Wolterbeek R, Jayne DR, Gaskin G, Rasmussen N, Noël LH, Ferrario F, Waldherr R, Hagen EC, Bruijn JA, Bajema IM: Clinical and histologic determinants of renal outcome in anca-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 2006;17:2264-2274.
19. Sinico RA, Di Toma L, Maggiore U, Tosoni C, Bottero P, Sabadini E, Giammarresi G, Tumiati B, Gregorini G, Pesci A, Monti S, Balestrieri G, Garini G, Vecchio F, Buzio C: Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 2006;47:770-779.
20. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P: Churg-Strauss syndrome: clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
21. Eustace JA, Nadasdy T, Choi M: The Churg-Strauss syndrome. J Am Soc Nephrol 1999;10:2048-2055.
22. Weidanz F, Day CJ, Hewins P, Savage CO, Harper L: Recurrences and infections during continuous immunosuppressive therapy after beginning dialysis in ANCA-associated vasculitis. Am J Kidney Dis 2007;50:36-46.
23. Bosch X, Guilabert A, Espinosa G, Mirapeix E: Treatment of antineutrophil cytoplasmic antibody associated vasculitis: a systematic review. JAMA 2007;298:655-669.
24. Bourgarit A, Le Toumelin P, Pagnoux C, Cohen P, Mahr A, Le Guern V, Mouthon L, Guillevin L: Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients. Medicine (Baltimore) 2005;84:323-330.